Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
Intel ended a fifth straight week lower while the chipmaker announced a strategic partnership with Lens Technology aimed at advancing semiconductor packaging using glass substrates, a critical step between chips and end products.
THE APEX TIMES
THE APEX TIMES
The companies agreed to halt their pending $111 billion merger until June 1, 2027, or until a federal judge rules on a case brought by state attorneys general, according to a report citing Paramount.
THE APEX TIMES
A recent market analysis argues that the shares may be trading at a premium to near-term metrics, while investors willing to look forward could effectively be buying the company at a discount to a later, more “normalized” valuation.
THE APEX TIMES
A market note from UBS suggests Starbucks’ ongoing turnaround work may improve US comparable sales results enough to run ahead of what investors are currently modeling.
THE APEX TIMES
In a recent interview, Amy Oldenburg, Morgan Stanley’s head of digital asset strategy, said the firm is preparing for a world where tokenized assets and digital rails become part of everyday capital markets workflows.
THE APEX TIMES
Intel posted second-quarter per-share earnings that were nearly double analysts’ expectations, yet investors appeared more focused on the broader question of how quickly customers are committing to artificial-intelligence spending.
THE APEX TIMES
The chipmaker reported results that beat forecasts by roughly $1.7 billion, yet investors sold the stock, pointing to broader pressures tied to oil, interest rates, and expectations around chip sales. Market commentary also latched onto a separate narrative shift involving Jim Cramer.
THE APEX TIMES
A Yahoo Finance report said analysts raised price targets after AMD’s latest push tied to artificial intelligence compute, sending a announcement of renewed confidence in its roadmap for AI-enabled PCs and data center systems.
THE APEX TIMES
In comments after its second-quarter 2026 results, HCA Healthcare said it is pushing ahead with growth initiatives while managing pressure from payer mix changes and a decline in elective surgeries.
